Skip to main content

Table 2 Clinical and molecular data on breast cancer patients (test set).

From: Predictors of primary breast cancers responsiveness to preoperative Epirubicin/Cyclophosphamide-based chemotherapy: translation of microarray data into clinically useful predictive signatures

Case

Response

Tumor reduction, %

Histology pre

Age

ER

PR

BCL2

P53

KI67, %

CerbB2

Grading

BC1843

NC

0

invasive ductal; bifocal

63

1

1

200

0

18

1+

2

BC1850

NC

0

invasive lobular

58

1

1

300

0

6

0

2

BC1862

NC

0

invasive lobular a. intraductal

59

1

1

196

0

11

1+

2

BC1871

NC

10

invasive lobular

46

1

1

140

1

24

0

2

BC1869

pCR

100

invasive ductal

60

0

0

0

0

50

0

3

BC1864

pCR

100

invasive a. intraductal (DCIS; 80%)

55

0

0

0

0

50

0

2

BC1421

pCR

100

invasive lobular

71

0

0

0

1

26

0

2

BC1870

cCR

100

invasive ductal

43

0

0

0

1

35

1+ to 2+

2

BC18611

PR

40

invasive ductal a. intraductal (very small)

36

0

0

0

0

35

0

3

BC1879

PR

47

invasive ductal

37

1

1

500

0

45

0

2

BC1866

PR

40

invasive lobular

52

1

1

300

1

24

2+ to 3+

2

BC1837

PR

90

invasive ductal

69

0

0

0

0

48

1+

3

BC1838

PR

80

invasive lobular

59

1

0

50

0

20

1+ to 2+

2

BC1842

PR

92

invasive ductal

68

0

0

0

0

29

1+

2

BC1834

PR

0

invasive ductal a. intraductal (very small)

60

1

1

30

0

10

3+

3

BC1858

PR

0

invasive lobular

62

1

1

140

0

16

1+

2

BC1880

PR

40

invasive ductal and intraductal (5%)

62

1

1

200

0

26

0

2

BC1881

PR

62

invasive ductal

72

0

0

0

1

22

0

2

BC1849

PR

22

invasive ductal

52

1

0

200

0

19

3+

2

BC1839

PR

10

invasive ductal

62

0

0

45

1

16

0

2

BC1513

PR

33

invasive lobular; multicentr.

60

1

1

300

0

10

0

2

BC1877

PR/NC

50

left: invasive lobular a. CLIS Type-A

53

1

1

300

0

6

1+

2

BC1853

PR/NC

0

invasive lobular

51

1

1

400

0

14

0

2

BC1448

PR

68

medullary invasive

50

1

1

30

1

38

3+

3

BC1134

PR/NC

5

invasive lobular

73

1

0

70

0

14

0

2

BC18402

PR

25

invasive ductal

45

1

1

60

0

35

2+ to 3+

3

BC1848

PR

85

invasive ductal; bifocal

42

1

0

500

1

28

3+

2

  1. Note: 1 – This patient has received 4 × EC and, additionally, 4 × Taxol; 2 – this patient has received 3 × EC and, additionally, 3 × FEC.